News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
238
Sources here
24
Companies here
8
Search results Stored financial headlines

Active search

238 matching headlines

Ticker or company: ALIGMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kuehn Law Encourages Investors of Alight, Inc. to Contact Law Firm

NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Alight, Inc. (NYSE: ALIT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Alight disseminated materially false …

ALIT main company
Sharemaestro market context Price below Trend Line 52 weeks -81.7% ALIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors following allegations of accounting irregularities. A whistleblower lawsuit filed on July 8, 2026, claims the company misclassified operating expenses in 2024 and 2025 to inflate its EBITDA, leading to …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology stock trades down amid ongoing selling pressure and oversold signals

Align Technology (ALGN) stock is trading down by 0.73% today, reflecting strong selling pressure and consistently oversold signals. The stock is well below its short- and medium-term averages, with momentum and oscillator indicators pointing to extreme oversold conditions and weak trend strength. Analysts predict …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aligos Therapeutics Inc (ALGS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on Aligos Therapeutics Inc (ALGS) stock, specifically focusing on its dividend history and stock split events. It states that no dividends have been distributed in the past five years and lists multiple upcoming stock split events scheduled for August 15, …

ALGS main company
Sharemaestro market context Price above Trend Line 52 weeks -32.5% ALGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aligos Therapeutics Inc (ALGS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Aligos Therapeutics Inc (ALGS), listing its major shareholders and their proportions, as well as a breakdown of shareholder types. It also provides institutional shareholding data over several quarters and recent shareholder activity with changes in holdings.

ALGS main company
Sharemaestro market context Price above Trend Line 52 weeks -32.5% ALGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions

Alignment Healthcare (ALHC) stock has seen a significant 237.9% return over three years but is currently screening as undervalued in Simply Wall St's checks. The company faces fresh legal and regulatory questions, including whistleblower allegations and a lawsuit concerning Medicare Advantage star ratings, which …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare (ALHC) Stock Looks Reasonable On Its 238% Three Year Run

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Alignment Healthcare stock has surged over the past three years, yet the recent pullback and a strong overall value score raise a clear …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ETFs Investing in Alignment Healthcare, Inc. Stocks

This article lists various ETFs that include Alignment Healthcare, Inc. (ALHC) stocks in their portfolios. It provides a detailed table with each ETF's market value, weight of ALHC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Unveils New Digital Dentistry Innovations

Align Technology has introduced new innovations within its Align Digital Platform, designed to enhance the visualization, planning, and treatment aspects of digital dentistry. These updates include improved patient communication tools, more precise treatment planning capabilities for Invisalign cases, and streamlined workflows for both orthodontic …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avoiding Lag: Real-Time Signals in (ALGS) Movement

The article discusses real-time trading signals for Aligos Therapeutics Inc. (ALGS), highlighting weak sentiment across all time horizons that supports a short bias. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also …

ALGS main company
Sharemaestro market context Price above Trend Line 52 weeks -32.5% ALGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology stock trades lower after softer Q1 2026 revenue and cautious outlook

Align Technology's stock fell after reporting softer-than-expected Q1 2026 revenue of $1.0 billion and a 17% decline in diluted earnings per share to $1.50, missing analyst consensus. The company issued a cautious full-year 2026 outlook, projecting mid-single-digit revenue growth and continued margin pressure, despite …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Inc (ALGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Align Technology Inc (ALGN) has an earnings forecast score of 7.79, ranking 122nd in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $175.00, with current ratings showing a consensus to "Buy" based on 19 analysts. The company's expected …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALGN|Align Technology Inc|Price:168.270|Chg%:-4.190

Align Technology Inc. (ALGN) is a global medical device company known for its Invisalign system of clear aligners and iTero intraoral scanners. The company's financials include a market cap of $11.97 billion and a P/E TTM of 28.00. Institutional holdings show 1683 institutions collectively …

ALGN main company ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UBS Adjusts Price Target on Align Technology to $189 From $186, Maintains Neutral Rating

UBS has adjusted its price target for Align Technology (ALGN) shares to $189 from $186, while reiterating its Neutral rating on the stock. This update reflects a modest revision in the valuation outlook for the company by the financial firm.

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare Under Investigation for Fraud Claims

Alignment Healthcare (ALHC) is under investigation by Pomerantz LLP and other firms following whistleblower allegations of accounting irregularities that artificially inflated the company's Adjusted EBITDA. A former executive filed a complaint on July 8, 2026, claiming financial manipulation. This news caused Alignment's stock price …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Announces New Innovations to Advance Invisalign® Treatment Planning and Enhance Patient Engagement Through Its Integrated Align™ Digital Platform

Align Technology (NASDAQ: ALGN) has introduced new innovations to its Align™ Digital Platform, including advanced Invisalign planning tools and enhanced patient engagement features. These updates allow doctors to visualize treatment options and outcomes more clearly, with features like 3D Tissue Animation and the Invisalign® …

A1LG34 main company ALGN main company ALGN main company AFW main company
Sharemaestro market context Price above Trend Line 52 weeks +22.6% · Next-week setup negative 39.0% A1LG34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Reasons to Retain Align Technology Stock in Your Portfolio for Now

Align Technology (ALGN) is expected to see significant growth due to international expansion and advancements in its iTero intraoral scanning technology. Despite potential headwinds from a dull macroeconomic environment and unfavorable foreign exchange movements affecting sales, the company's geographic expansion in EMEA and APAC, …

A1LG34 main company ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +22.6% · Next-week setup negative 39.0% A1LG34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Urges Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after a former executive filed a whistleblower complaint alleging accounting irregularities and inflated financial results. The complaint claims operating expenses were misclassified as capital expenditures, leading to a …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALGS Q2'26 Earnings: revenue estimate is 24.68M USD

Aligos Therapeutics, Inc. (ALGS) is scheduled to release its Q2'26 earnings on July 30, with an estimated revenue of $24.68 million and an anticipated EPS of ($1.09). The article provides a table detailing past revenue and EPS performance, including reported and estimated figures and …

ALGS main company
Sharemaestro market context Price above Trend Line 52 weeks -32.5% ALGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

3 Healthcare Stocks with Competitive Advantages

3 Healthcare Stocks with Competitive Advantages From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry's returns lately - over the past six …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALHC6247090 Bond Profile — Key Metrics

This article provides key financial metrics for the ALHC6247090 corporate bond issued by Alignment Healthcare, Inc. It details the bond's coupon rate, maturity date, issue date, outstanding amount, and face value. The company, founded by John E. Kao in 2013, focuses on offering consumer-centric …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alignment Healthcare, Inc. (ALHC) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Alignment Healthcare, Inc. (ALHC) following allegations from a whistleblower lawsuit. The lawsuit claims that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its adjusted EBITDA. This news led to …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare Inc (ALHC) Shares Fall 3.4% -- What GF Score of 78 Tells Investors

Alignment Healthcare Inc (ALHC) shares recently fell 3.4% to $20.77, trading above its GF Value™ estimate of $19.44, indicating it is 6.8% overvalued. The stock holds an Above Average GF Score™ of 78/100, driven by a strong Growth rank (10/10) but tempered by lower …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology stock holds near 2026 levels as investors track margins

Align Technology's stock performance remains closely tied to its latest quarterly results, with revenue at $1.01 billion and a strong gross margin of 70.4%. Investors are focused on the company's ability to sustain revenue growth and margin durability in 2026, especially concerning its Invisalign …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox is Investigating Claims on Behalf of Alignment Healthcare, Inc. (ALHC) Investors for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of accounting irregularities that artificially inflated the company's financial results. This news led to a significant drop in Alignment Healthcare's stock price. …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alight director Kausik Rajgopal buys $780 in company stock

Alight director Kausik Rajgopal purchased 38 shares of the company's Class A common stock for $780 on December 15, 2025, through a dividend reinvestment program. The shares were acquired at $20.5303 per share, adjusted for a recent 1-for-20 reverse stock split. This transaction increases …

ALIT main company
Sharemaestro market context Price below Trend Line 52 weeks -81.7% ALIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy With 18% Potential Upside

Alignment Healthcare, Inc. (ALHC) is presented as a compelling investment opportunity in the healthcare sector, particularly appealing to growth-oriented investors. With a market capitalization of $4.36 billion, the company focuses on Medicare Advantage plans for seniors, showing strong revenue growth of 33.30% and an …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Notifies Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower complaint alleged "accounting irregularities" that artificially inflated the company's financial results and executive compensation. Following news of the complaint on July 8, 2026, Alignment …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALIGNMENT HEALTHCARE INVESTOR ALERT: Bragar Eagel & Squire,

Bragar Eagel & Squire, P.C. is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following allegations of financial manipulation. A former executive filed a whistleblower lawsuit claiming the company misclassified operating expenses as capital expenditures to inflate its adjusted EBITDA and stock price. Following …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alight to Announce Second Quarter 2026 Results

CHICAGO, July 21, 2026--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT or "Alight") today announced it will release second quarter 2026 earnings results after market close on Tuesday, August 4, 2026, and management will host a webcast to discuss the results at 4:30 p.m. ET. The webcast …

ALIT main company
Sharemaestro market context Price below Trend Line 52 weeks -81.7% ALIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology (ALGN) Q4 2024 Earnings Report - Results, Call & Slides

Align Technology (ALGN) released its Q4 2024 earnings report, revealing an EPS of $2.44, which slightly missed the consensus estimate of $2.45. The company also reported actual revenue of $995.22 million, missing the expected $996.90 million. YoY revenue growth was 4.02%, and the earnings …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology stock is supported by recent earnings metrics

Align Technology's stock is supported by its 2025 financial metrics, which include $4.0 billion in revenue, $470.6 million in net income, and diluted EPS of $6.43. These figures provide a concrete basis for evaluating the company's valuation and operational health. The article emphasizes using …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALHC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Kirby McInerney LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities laws violations. This follows a whistleblower lawsuit alleging that Alignment Healthcare manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its stock price and executive compensation. The firm …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Block & Leviton probes Alignment Healthcare for alleged securities violations after whistleblower lawsuit.

Block & Leviton is investigating Alignment Healthcare (ALHC) for alleged securities violations, stemming from a whistleblower lawsuit. The lawsuit claims the company manipulated financial results to inflate its stock price and executive compensation. This follows a significant 16.72% stock drop after the lawsuit news, …

ALHC main company
Sharemaestro market context Price below Trend Line 52 weeks -11.9% ALHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context